I'd imagine it would be related to and this could change! They've done the echo chamber to death, anyone interested in stem cells and allogeneic obviously wants to succeed at this. The focus for mesoblast appears to be now on the wider medical community, about getting FDA approval being the number 1 priority, about the doctors and surgeons out their who currently treat to adopt to stem cells.
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-643
-
- There are more pages in this discussion • 263 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |